MicroPort HeartTech Records Over HK$30 Billion in Margin Subscriptions, Oversubscribed by More Than 130 Times
Jan 27, 2021 15:31
CST Updated
15:31
MicroPort CardioFlow
A Provider of High-End Interventional Medical Devices in the Cardiac Valve Field, Engaged in R&D, Manufacturing, Sales, and Related Technical Consulting Services
MicroPort
High-end Medical Device R&D and Manufacturer
January 27 News: MicroPort CardioFlow Medtech Corporation began its initial public offering today. Based solely on margin financing subscriptions, MicroPort CardioFlow has temporarily recorded over HK$30 billion in margin subscriptions, with an oversubscription ratio exceeding 130 times. The investment community believes that subscribing to 350 lots is necessary to secure one lot with certainty.
Responsible Editor: Ma Jie